Improving the journey: Patient-focused advances with CD38 mAb quadruplet therapy
Thursday, May 14, 12:15-13:30 CEST
Join Drs. Philippe Moreau, Arthur Bobin, Aimee Merino, and Sikander Ailawadhi for an engaging, interactive symposium exploring the latest advances in CD38 monoclonal antibody (mAb)–based quadruplet therapy. This program will focus on optimizing the patient journey by addressing key patient concerns, enhancing treatment outcomes through effective use of CD38 mAb quadruplets, reviewing the most recent clinical data in both transplant-eligible and transplant-ineligible patients, and discussing novel administration approaches to further improve patient experience and outcomes.
| AGENDA | |
|---|---|
| 12:15-12:22 | Welcome and introduction – Charting the course: Initiating patient-centered care from diagnosis through treatment Prof. Philippe Moreau, France |
| 12:22-12:39 | Setting out: Leveraging the power of CD38-based quadruplet therapy in Ti NDMM Dr. Arthur Bobin, France |
| 12:39-12:47 | Panel discussion ALL |
| 12:47-12:57 | Climbing new heights: Leveraging the power of CD38-based quadruplet therapy in Te NDMM Dr. Aimee Merino, United States |
| 12:57-13:02 | Panel discussion ALL |
| 13:02-13:14 | Navigating roadblocks: Addressing patient concerns to optimize therapy Dr. Sikander Ailawadhi, United States |
| 13:14-13:20 | Panel discussion ALL |
| 13:20-13:30 | Q&A and close ALL |
